CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06710366
NCT06710366N/ACompleted
CompareCT.gov

Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

AB Biotek·observational·Posted Nov 29, 2024·Updated Nov 29, 2024

In Brief

An observational study for DAO Genetic Variants. Completed, enrolled 200 participants across 1 site.

Detailed Summary

Observational study to estimate the prevalence of genetic DAO deficiency in the population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDAO Genetic Variants
CountriesSpain
CollaboratorsGrupo Hospitalario Quironsalud-Catalunya, Hospital Universitari General de Catalunya, Quironsalud

Timeline

N/ACompletedFinished
202420252026
First PostedNov 29, 2024
Enrollment StartFeb 28, 2023
Primary CompletionJun 21, 2024
Study CompletionJun 26, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 1.6 years ago